Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2016
IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell SubpopulationsTahseen H Nasti, J Barry Cochran, Raj V Vachhani, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivityNabiha Yusuf, Tahseen H Nasti, Chun-Ming Huang, et al.International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell-Dependent MechanismKishore Kumar Jella, Tahseen H Nasti, Zhentian Li, et al.Frontiers in Oncology|January 9, 2019
Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and FractionationZachary S Buchwald, Jacob Wynne, Tahseen H Nasti, et al.Cancer Research|May 17, 2008
Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesisNabiha Yusuf, Tahseen H Nasti, Santosh K Katiyar, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 20, 2015
Immunoprevention of chemical carcinogenesis through early recognition of oncogene mutationsTahseen H Nasti, Kyle J Rudemiller, J Barry Cochran, et al.Journal for Immunotherapy of Cancer|October 8, 2020
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapyZachary S Buchwald, Tahseen H Nasti, Judong Lee, et al.Journal of Virology|April 24, 2020
Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood VaccinationChristiane S Eberhardt, Andreas Wieland, Tahseen H Nasti, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2018
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patientAndreas Wieland, Alice O Kamphorst, N Volkan Adsay, et al.The Lancet. Haematology|May 26, 2024
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USAMohammad K Khan, Tahseen H Nasti, Joshua Y Qian, et al.Pageof 5